On Wednesday 14th August, the World Health Organization (WHO) declared that the rapidly emerging mpox outbreak in Africa had become a public health emergency of international concern (PHEIC
The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.